Gökbuget, Nicola ; Basara, Nadezda ; Baurmann, Herrad ; Beck, Joachim ; Brüggemann, Monika ; Diedrich, Helmut ; Güldenzoph, Björn ; Hartung, Gernot ; Horst, Heinz-August ; Hüttmann, Andreas ; Kobbe, Guido ; Naumann, Ralph ; Ratei, Richard ; Reichle, Albrecht ; Serve, Hubert 
; Stelljes, Matthias ; Viardot, Andreas ; Wattad, Mohammed ; Hoelzer, Dieter
; Stelljes, Matthias ; Viardot, Andreas ; Wattad, Mohammed ; Hoelzer, Dieter 
Zusammenfassung
Nelarabine, a purine analog with T-cell specific action, has been approved for relapsed/refractory T-cell acute lymphoblastic leukemia/lymphoma (ALL/LBL). This is a report of a single-arm phase 2 study conducted in adults (18-81 years of age) with relapsed/refractory T-ALL/LBL. After 1 or 2 cycles, 45 of 126 evaluable patients (36%) achieved complete remission (CR), 12 partial remission (10%), ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric